天津昂赛细胞基因工程有限公司根据国家发改委“发改高技〔2004〕275号”文件精神，在国家发改委和天津市人民政府的支持和资助下于2004年8月成立，位于天津滨海新区的细胞产品国家工程研究中心，主要从事细胞治疗产品、体内外分离与扩增干细胞、基因工程多肽药物等的研究开发，旨在加速干细胞工程技术开发和基因工程药物的科研成果向现实生产力转化。2008年，公司被列入天津市政府未来五年计划予以重点支持的滨海新区自主创新高新技术平台项目。公司内设有硕士、博士点和博士后工作站，拥有，其中博士4人、硕士研究人员5人，本科及以上学历51人。公司自建立以来，坚持走自主创新之路，采用先进的管理机制，集聚干细胞技术和人才优势，逐渐形成了技术、人才、经济良性循环发展模式。
天津昂赛细胞基因工程有限公司欢迎国内外致力于我国干细胞事业，生物产业的有识之士加盟，并欢迎为公司的建设和发展献技献策。
Introduction

Tianjin AmCellGene Engineering Co., Ltd. according to the national development and reform commission "hair changed high skill [2004] no." the spirit of the documents, 275 at the national development and reform commission and the people's government of tianjin support and funding in August 2004, is located in tianjin binhai new area of cellular products national engineering research center, is mainly engaged in product, the cell therapy and amplification stem cells, genetic engineering polypeptide drugs to accelerate the research and development of stem cell engineering technology development and gene engineering to the drug research into productive forces. In 2008, the company was listed in the tianjin government future five-year plan to support the binhai new area of independent innovation technology platform project. Company consists of the master, doctoral postdoctoral workstation and have experts, including four people, dr ma researchers 5 people, bachelor degree or above, 51. Company since its inception, adhere to the road of independent innovation, and adoption of advanced management mechanism, stem cell technology and talent advantages, and gradually formed a technology, talent, economic cycle development mode.
Tianjin AmCellGene Engineering Co., Ltd. Welcome to our business, biological industry of stem cells, and welcome the man of insight to join in the construction and development of the company for it.